HIV Alterations of Guidelines for Antiretroviral Therapy ... · Alterations of Guidelines for Antiretroviral Therapy in Patients with HIV Infection ... Yeni PG, Volberding PA : Antiretroviral

Post on 28-May-2020

8 Views

Category:

Documents

0 Downloads

Preview:

Click to see full reader

Transcript

� �� �

HIV�������� ���Alterations of Guidelines for Antiretroviral Therapy in Patients with HIV Infection

� � �Satoshi HIGASA

����������Department of Internal Medicine, Hyogo College of Medicine

����� : ���� ���� ������� HIV��� ������� ��������

���� �!" 0 : +./�+/+� ,**.

� � � �

�# $�HIV��% +33/��������&'(� )PI* +�,-David Ho+ .Hit HIV early and hard/+*

+�0-12�345� 678������ )NRTI*- PI+��29:Highly active antiretroviral therapy

)HAART* %;<=>2$?��$��� �@A3BCDECFG<2�?� HIHIVJ�K2L5:����

���+MN!OPQ�R+ International AIDS SocietySUSA )IAS-USA*,�1*TD� ������QDepartment of

health and human services )DHHS*2�+1*TD��U<� �V ��+WX-EYZ�U<Y?:F IAS-USA+OP%�[\ ,�]-2^�U<� ;+_2�D<C`E?�a3�b2c�U<Y?:+2 E� DHHS+������%� !"d$QD#$2^�U<� ���� ���2ef:�a3>g:h5%ij&'f:�(-$kY?:F lmU<Y?:�(3)nf:-� IAS-USA+OP%9o*p 2� DHHS+������%)n +q 2c�U<Y?:9r2as5D<:F=C� tR+2*u�,+3*2L?YB� ;<v<-w+������Q��U<Y?:Q� GG>% +330�xy+IAS-USA+OP� L9zDHHS+������+./-� ;+{|2}?Y~�:F

������

+330�+331�+33/�xy� HIV+0�1�+��� HIV-RNA2+3

"4�� PI+4�� ����+5@�$�� HIVJ��+67� ��+8�%�gj�9ECFG+�929o� HIVJ��+��4X%�gj�f:G-2$o� +330� 1�� IAS-USATD+OPQ The

Journal of the American Medical Association )JAMA* 2��U<C,*F :�+;�����(>%� CD.�<�Q/**�mlx�+�K2��34�f:G-Q��U<YLo� G<3s5YG+OP>B�=���HIVJ�K+��4��V% CD.�<��/**�ml, =C% CD.�<��/**�ml>BHIV-RNA2�-*,***�/*,*** copies�ml+,�-U<Y?C )� +� ��*F=���HIVJ�K2L?Y�HIV��3>d24�EC,��� +2�f?@Q�:��:�HIV+0�3�A2B�>gC,�2%� C -�>D�TDHIV3 E>g:¡F�Q�:-¢£D<Y?CG-Q� >dTD+��3¤¥f:{|-$kY?CFETE$QDG+OP2L?Y%� :�=h PI+��

@A2ef:�'���+¦GQ!§H>�kCC¨� ��4�I�%NRTI ,� )=C% ddIJ�* TDKLE�G<2 PI3©£:T�rT3ª��-�K-+MN>«"f:� -U<Y?CF;+¬� PI3©£CHAART%� ;<=>+��>%�D<$TkC­DE?@A3BCDE� G<D+5®�¯ToQOP}°A-$kCF G+C¨� +331� 0�+IAS-USA+OP-* >%��4��VQUD2>=o�HIV-RNA2Q /,***�+*,***copies�ml3Q£:,�%CD.�<�2e±$j��4�Q¤¥U<:G--$kC )� +� ²�*F G+OP2³£¯�]j´R3µg� HIV

J�K+[-¶�Q��S·2$:F´4� DHHS+������% +331� ++�2¸¨Y��U<2*� ��4��V% CD.�<� /**�mlTU� =C%HIV-RNA2Q ,*,*** copies�mlx�+,�2%��3¤

�KVW* : ¹00-�2/*+ º»¼X�YZ +�+ ����������Fax : *132�./�0/3-

,**.� 2� ,�s[

�,**. The Japanese Society for AIDS Research The Journal of AIDS Research

) -3 *+./

�������� �� � +330�� IAS-USA�������������� ��������� -/*�/**�ml�HIV-RNA�� ,*,*** copies�ml� �!"��� #��$�%�&�'()�*�����+,-����./0� +330�12 +332�3��� 3,�4 5Hit

HIV early and hard6 ���78�&�)9:��;�,-�<=����+332�,***��1�� >�?HAART)@A����B�CD�

��E-� BFHIVGHI�JK�LHIV��M(NO�PQR+.S T� +S �� U�� 5Hit HIV early and

hard6 � 5early6 �E��V����WO*��X12� �YZ[�\Q�]^)�_���*��

3/��`�����ab����� >-)c9�AK���d4�eI����f���8� YZ[�\Q�^B�CD��� ��g.hi(j�k��lmU��W�� ��n� ,op�qr2-���i(stu�HIV

GHv��w�� .-xy�`�8� HIVCz){|��}�W����� 0*��`HIV�~�12 ��a!�����"#��� �HAART�����HIVCz){|��}�����a!�"#��� �$��Q���������,-��� &������������a!�.��W�� �,2�%-��������CD�E�K���� .��������#21�.8� IAS-

USA������ &�NO� ����?�)O*���.�� T� +� � � � S

� + BFZ HIVGHI����&��'(�M(NO�PQRJ��&�

&�NO'(�&�

�QOL)�.:��� ' T����(,)S������*�¡¢� '���YZ[�\Q�^<(�£'�¤+� HIV¥e�PQR�¦§�.��<����a!.��)¦§¨©t

&�NO'(�PQR

��aªj.$�«�¬,�[�\Q-­��}��8f��.�a!Z�HIV®.�PQR�C§��a!Z

M(&�NO�&�

�[�\Q-­�}¯°�>�±²�/³�$�«�´!µ �£'0�1��{|.[�\Q�}�����YZ[�\Q�^PQR�µ �HIV®.�PQR)¶·,¸�a!Z

M(&�NO�PQR

��������� QOL�µ ������*�¡¢�2¹jCD�[�\Q�}��º3.!"���YZ[�\Q�M(�^�¤+��a!.���}¨

� + BFZ HIVGHI����&�NO� TIAS-USAS �4» T,***� +y�¼S

S Higasa : Alterations of Guidelines for Antiretroviral Therapy in Patients with HIV Infection

T .* S+.0

,**+���,**+����������� ��������������� DHHS������� ! ,**+� ."�#$+-%&�� CD.'() -/**,**�ml�+�,-./0123 ,%45� IAS-USA�67�� ,**,�0% &�������

8 CD.'() ,**�ml�+./ � 90:;��<=�>?�;�/023 -%1 @�#$ �� CD.'()8 ,**�ml�A�,-�� BC�DEF.� CD.'().GHIJ� HIV-RNAK� DE����LM?NO� P�QP��R�ST8UV&� BWX�Y���ZR[� \]^_`a� <bc�deM?.�Yf98� ,**.��gh

#$�Y� CD.'()8 ,***-/*�ml�,-�����<BW�ci� -/*�ml�A�,-���jk./0f9?1%1@��;��������@@)����5l�mn 9?8� oHit HIV early and hardp �qr!HIVstu����vw x?1 y� zqr���\<!0f� {|8@�w<}~���?��.f!��9� @.8�����k<=�>f9?�M�/91�����8 ������8��� �k��`a�/9���/\�8���YY�� �����k�gh�k�.���Yf9�.c��Y?1

� , �u�� HIVstE�LM?������ 2IAS-USA% ��� 2,**,� 1"��%

� - �u�� HIVstE�LM?������ 2DHHS% ���

The Journal of AIDS Research Vol. 0 No. - ,**.

2 .+ %+.1

������

�������� +330� IAS-USA�� �� ������� Zidovudine (AZT)�didanosine (ddI), AZT

�zalcitabine (ddC), AZT�lamivudine (-TC),���� ddI

��� PI������������ !"��# +331$%�NRTI ,�� PI&���'()*+,-./0�1NNRTI2 +��34� -���567�8� IAS-USA

�� � 9:;����<=���>?�8@8A�#B!�C� DHHS�DEFGEH� +331IJKL&� �������MN�����9:;��?��O� P�QRSTU���;67 VW;67 XY;�67 !8� 67 !8� � .Z�������>?�"��#

DHHS�DEFGEH� +331IJ ,**,&� ������� PI����NRTI�[\�]� Column A

� NRTI ,��<�� Column B��^ B� Column

A�BP!_!IJ +Z�VW`�Vabc�QRSTU��?�"�� 1d .2# �I� ��;67� !"��VW`� Column A�B�e� .f0g�e�A��467 !�QRSTU�Sh +0f-0g��8A"��#&� i���jklmn�o���5pq]��r�VW`5s� !�� *���jklmn5t�u�VW`�X�5vw !����# B��4 xy���;67�VW`�z!5���I5 { |$}��TI��@���~��e�A�#

DHHS�DEFGEH� ,**- 1������� ! �������QRSTU� NNRTI����]�QRSTU PI����]�QRSTU NRTI -��Q

RSTU� -g����@����� KL��A"��1d /2# B!� Column A�B�yx�VW`IJP!_! +Z�Vabc� Tenofovir 1TDF2 l Atazanavir

1ATV2 �i~8 Column A�B��������Z���pq�i� B!&���������5��"��B����@���J!�# J�B����� xy@�A���;67�VW`�X�� /g������&!"�� i���l]�e� � � � � � " � �# B ! � Efavirenz 1EFV2 lLopinavir-Ritonavir 1LPV�r25 P!&���������"�����jk�mn5o�����5 ¡���4���J!�#X�� IAS-USA�� e ,**.IJ¢r67]�������&�4�i~�8� KL��A"�� 1d/2#B�i~� �������VW������£i�e J��¤��� !"�� ¥¦e§��pq �N8¨©;����ªK8z�iA" 67����« !¬^���­~���J!�#

����

����«���� ��jk5�®�8qS 1��¯°2 � ����� l����i�qS5��# ��¯°�]��£� DHHS�DEFGEH�� +331IJ,**,&�� HIV-RNA�5���� .f2±� +�+*$²�8J8� �HIV-RNA�5���� .f0³�¦�´ª��$²�8J8� �HIV-RNA�5Xµ´ª��$²�8A�5 ¢r¶� �HIV-RNA�5·²�� -

¸$O�¶� � NRTI ,��i����iA"HIV-

� . ¹º��67�� 1DHHS2 ��» 1¼@67 !�e�2

S Higasa : Alterations of Guidelines for Antiretroviral Therapy in Patients with HIV Infection

1 ., 2+.2

RNA��������� �CD.��� � ,���������� �������� ������� ��� ! ,**-� 1"+/#�$���%��� �%&�� !� '()*+�, : � -./& ,.0�HIV-RNA�1.** copies�ml, � -./& .20�HIV-RNA�1/*

copies�ml, �HIV-RNA��2��������34��561.** copies�ml7�8� 9+�, : �-./ +

�&� CD.��-./�:; ,/</*�ml���8=3�� � CD.��-./�:;� � ���, : -./ ->"�&�HIV?�@A��BC�D=� 95E�FGHIJK#� ���� L�M�+.#��N=��:;�O�3P���Q��%IRST:U�34�� �V���$��!� -,�WXIYZ*[\]=� Y^_Y`\*� �Q���a� bT�!����������WX�34��Tcd�!� L��eIR�fT��I��:;gh�=��T�2 � IAS-USA�ij�!� ��M�-,��

�k��� DHHS�l(^`(\mn!I"��!#o��3��

������

IAS-USA�ij�! +331�-# M�� -,p��Q�%�k��q���Q$Irs=�%Its=����=u=� ��%!v�HAART���NRTI&Q� bT�! ,QuV��%�vwIx��g��b4�� HAART

�2'�=� +332�.#�!�q���Q$Irs=�%!3K3;� �Q�y`*Irs=�%�ts���� ()��DHHS�l(^`(\�g� +333� /"++#M�!q���Q$Irs=�%Its=����� ,***� +"+,#

uVts��3K34��T� *p!�Q�%�?fTz{|� 3K� �%&�-}~g+�,�b4���� ��3�HIV��-����� q���rsfT����.�34���� 3n�L�/0�RSV�T�L�&� �Q1a����2��T�3�� 1a����~I�R�=��Q�%�����T:U�34��,***� +"+,#uVDHHS�l(^`(\�! ��Q1a����4�?fTij� �ts���x;� ,**-� 1

"+/#uV� L�M��-�%��V���Tcd�� �5g�%I����Tcd� x:6�Q1a���Ig��=��Q�%�RS I%�M�o��T� 2 �IAS-USA�ijg ,**,�0# �� -,p��Q�%�k��� �Q1a����~I26��;7��%Its=��T�-,p��Q�%�k��!� 8������g�����/��/o�9��!bT�� :D���������;��x;�L�}~g�,�!�S3���4���%IR�fT��!� ��<=3 >¡7�¢\£)]�ioV���T�

� �

L�?� DHHS�l(^`(\!� $�I�¤¥¦T�k��� �Y^_Y`\*�� ��HIV�x:6HAART�?fT@§@A�� �¨a�x�T�©]ª'()*A�?fT�B@«�� �HIV¬­®¯��fT¬­C°>'\Z±\²�� �+D +�EF�-� ��Q³GH5´µ|�3n�Ir��T:U�3;� ��!�8fT2 �bT� ��VIJ�¶·fT��!�¸3��o� ¹!WKI�º�����

/ ,**.�B»L¼������T-./�Q

The Journal of AIDS Research Vol. 0 No. - ,**.

C .- #+.3

� � � �

HIV���������� ����� �� �������������� !"#$%&'( )�)�*�+ ,-./0#1%&'HAART�+ .2.23456���/7�+ 8�9:;�<=>?@ABCDE�FG*HI( .'+ J'���K���L�M3+ N�OPQ�RBHS�0T/7U( )'*$%V1��WXYZX��[\B]^_`*0#1%Ia��bc�1�I(de�fJ)IWXYZX�ghi)jj+ HIV������fkl;/7UV!Bm.n'6/+ �o!pGq)rI+ ��stguE)%IaV!*vw/7U(

� �

+ x Ho DD, Neumann AU, Perelson AS, Chen W, Leonard

JM, Markowitz M : Rapid turnover of plasma virions

and CD. lymphocytes in HIV-+ infection. Nature -1- :

+,-�+,0, +33/.

, x Carpenter CC, Fischl MA, Hammer SM, Hirsch MS,

Jacobsen DM, Katzenstein DA, Montaner JS, Richman

DD, Saag MS, Schooley RT, Thompson MA, Vella S,

Yeni PG, Volberding PA : Antiretroviral therapy for

HIV infection in +330. Recommendations of an interna-

tional panel. International AIDS Society-USA. JAMA

,10 : +.0�+/., +330.

- x Carpenter CC, Fischl MA, Hammer SM, Hirsch MS,

Jacobsen DM, Katzenstein DA, Montaner JS, Richman

DD, Saag MS, Schooley RT, Thompson MA, Vella S,

Yeni PG, Volberding PA : Antiretroviral therapy for

HIV infection in +331. Updated recommendations of the

International AIDS Society-USA panel. JAMA ,11 :

+30,�+303, +331.

. x Carpenter CC, Fischl MA, Hammer SM, Hirsch MS,

Jacobsen DM, Katzenstein DA, Montaner JS, Richman

DD, Saag MS, Schooley RT, Thompson MA, Vella S,

Yeni PG, Volberding PA : Antiretroviral therapy for

HIV infection in +332 : Updated recommendations of

the International AIDS Society-USA Panel. JAMA ,2* :

12�20, +332.

/ x Carpenter CC, Cooper DA, Fischl MA, Gatell JM,

Gazzard BG, Hammer SM, Hirsch MS, Jacobsen DM,

Katzenstein DA, Montaner JS, Richman DD, Saag MS,

Schechter M, Schooley RT, Thompson MA, Vella S,

Yeni PG, Volberding PA : Antiretroviral therapy in

adults : Updated recommendations of the International

AIDS Society-USA Panel. JAMA ,2- : -2+�-3*, ,***.

0 x Yeni PG, Hammer SM, Carpenter CC, Cooper DA,

Fischl MA, Gatell JM, Gazzard BG, Hirsch MS,

Jacobsen DM, Katzenstein DA, Montaner JS, Richman

DD, Saag MS, Schechter M, Schooley RT, Thompson

MA, Vella S, Volberding PA : Antiretroviral treatment

for adult HIV infection in ,**, : Updated recommenda-

tions of the International AIDS Society-USA Panel.

JAMA ,22 : ,,,�,-/, ,**,.

1 x Yeni PG, Hammer SM, Hirsch MS, Saag MS, Schechter

M, Carpenter CC, Fischl MA, Gatell JM, Gazzard BG,

Jacobsen DM, Katzenstein DA, Montaner JS, Richman

DD, Schooley RT, Thompson MA, Vella S, Volberding

PA : Treatment for Adult HIV Infection. ,**. Recom-

mendations of the International AIDS Society-USA

Panel. JAMA ,3, : ,/+�,0/, ,**..

2 x The panel on clinical practices for treatment of HIV

infection. Guidelines for the use of antiretroviral agent in

HIV-infected adults and adolescents. Department of

Health and Human Services (DHHS) Nov ++, +331.

http : //aidsinfo.nih.gov/guidelines/

3 x The panel on clinical practices for treatment of HIV

infection. Guidelines for the use of antiretroviral agent in

HIV-infected adults and adolescents. Department of

Health and Human Services (DHHS) Mar -+, +332.

http : //aidsinfo.nih.gov/guidelines/

+*x The panel on clinical practices for treatment of HIV

infection. Guidelines for the use of antiretroviral agent in

HIV-infected adults and adolescents. Department of

Health and Human Services (DHHS) Dec +, +332.

http : //aidsinfo.nih.gov/guidelines/

++x The panel on clinical practices for treatment of HIV

infection. Guidelines for the use of antiretroviral agent in

HIV-infected adults and adolescents. Department of

Health and Human Services (DHHS) May /, +333.

http : //aidsinfo.nih.gov/guidelines/

+,x The panel on clinical practices for treatment of HIV

infection. Guidelines for the use of antiretroviral agent in

HIV-infected adults and adolescents. Department of

Health and Human Services (DHHS) Jan ,2, ,***.

http : //aidsinfo.nih.gov/guidelines/

+-x The panel on clinical practices for treatment of HIV

infection. Guidelines for the use of antiretroviral agent in

HIV-infected adults and adolescents. Department of

Health and Human Services (DHHS) Apr ,-, ,**+.

http : //aidsinfo.nih.gov/guidelines/

S Higasa : Alterations of Guidelines for Antiretroviral Therapy in Patients with HIV Infection

y .. x+/*

+.� The panel on clinical practices for treatment of HIV

infection. Guidelines for the use of antiretroviral agent in

HIV-infected adults and adolescents. Department of

Health and Human Services (DHHS) Feb .. ,**,.

http : //aidsinfo.nih.gov/guidelines/

+/� The panel on clinical practices for treatment of HIV

infection. Guidelines for the use of antiretroviral agent in

HIV-infected adults and adolescents. Department of

Health and Human Services (DHHS) July +.. ,**-.

http : //aidsinfo.nih.gov/guidelines/

+0� The panel on clinical practices for treatment of HIV

infection. Guidelines for the use of antiretroviral agent in

HIV-infected adults and adolescents. Department of

Health and Human Services (DHHS) Nov +*. ,**-.

http : //aidsinfo.nih.gov/guidelines/

+1� The panel on clinical practices for treatment of HIV

infection. Guidelines for the use of antiretroviral agent in

HIV-infected adults and adolescents. Department of

Health and Human Services (DHHS) Mar ,-. ,**..

http : //aidsinfo.nih.gov/guidelines/

+2� ����� ��� � � : �HIV��������� �� +.������� !"#$%&' (�)*+"#,- .HIV/012��3456"#78� ,**-.

+3� Pozniak A, et al : British HIV Association (BHIVA)

guidelines for the treatment of HIV-infected adults with

antiretroviral therapy. HIV Med Suppl + : +�.+, ,**-.

The Journal of AIDS Research Vol. 0 No. - ,**.

9 ./ �+/+

top related